Taken together, these results not only establish a reliable in vitro model of PE-induced cardiomyocyte hypertrophy characterized by S100A10 upregulation., but also highlight the differential regulation of S100A10 across distinct cardiomyopathy subtypes, suggesting potential subtype-specific roles in disease pathogenesis. This evidence concerns the gene S100A10 and cardiomyopathy.